The independent source for health policy research, polling, and news.
1-20 of 107 results
The campaign to defend access to transgender healthcare for young people in Missouri is taking an unhurried approach to talking with voters about how the ban on midterm ballots would play out.
Massachusetts passed laws and joined lawsuits to protect access to gender-affirming care for minors. But faced with the Trump administration’s threats, some hospitals voluntarily stopped care. Families are outraged.
Despite public opposition to the cuts they made to federal health programs in 2025, Republicans reportedly are considering more cuts to help pay for the war in Iran. Meanwhile, the Supreme Court ruled that Colorado cannot ban “conversion therapy” for LGBTQ+ minors. Jessie Hellmann of CQ Roll Call, Alice Miranda Ollstein of Politico, and Sandhya Raman of Bloomberg Law join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Elisabeth Rosenthal, who wrote the last two “Bill of the Month” stories.
The Trump administration faces the challenge of naming a new director of the Centers for Disease Control and Prevention who can both satisfy the Make America Healthy Again movement and get confirmed by the Senate. Meanwhile, a new Senate bill to rescind the approval of the abortion pill mifepristone is again elevating the abortion debate, which some Republicans would prefer to stay on the back burner until after the midterms. Shefali Luthra of The 19th, Lizzy Lawrence of Stat, and Rachel Cohrs Zhang of Bloomberg News join KFF Health News’ Julie Rovner to discuss the news. Also this week, Rovner interviews Georgetown University Law Center’s Katie Keith about the state of the Affordable Care Act on its 16th anniversary.
With lawmakers still mired over renewing enhanced tax credits for Affordable Care Act plans, much of Washington has turned to culture war issues. Meanwhile, “confusion” remains the watchword at HHS as personnel and funding decisions continue to be made and unmade with little notice. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews KFF Health News’ Elisabeth Rosenthal, who wrote the latest “Bill of the Month” report.
It’s been more than 10 years since the FDA first approved an HIV prevention drug. Today, people who could benefit from preexposure prophylaxis often struggle to access the lifesaving medicine or run into doctors without the education or empathy to offer affirming care. And those lapses can produce billing headaches.
In 2026, U.S. cancer registries that receive federal funding will be required by the Trump administration to classify patients’ sex as only male, female, or not stated/unknown.
HIV physician John Weiser talks about why complying with President Donald Trump’s orders to erase transgender people is bad for science and society. And he notes that acquiescing didn’t spare the CDC from further harm.
Demand for home health care, including at-home hospice care, has skyrocketed since the onset of the covid pandemic. A New Orleans nonprofit is teaching people how to provide end-of-life care for relatives and community members.
Under Trump policies, cancer registries in 2026 will have to classify sex data strictly as male, female, or unknown, a change scientists and advocates say will harm the health of one of the nation’s most marginalized populations.
California Gov. Gavin Newsom vetoed a bill that would have expanded access to hormone therapy, a top priority for the trans community. Advocates say it would have ensured continuity in gender-affirming care amid Trump administration attacks. Analysts say it’s another sign of the Democrat’s move to the center.
LGBTQ+ youth lost dedicated support on the 988 Suicide & Crisis Lifeline in July at a critical time. Advocates say mental health issues are rising in that population amid hostility from the Trump administration.
Native American groups declare that tribal sovereignty trumps state and federal efforts to restrict or ban gender-affirming care for two-spirit and LGBTQ+ tribal citizens. Tribes are analyzing the risk of opposing Trump’s policies, advocates say.
Medicaid may have monopolized Washington’s attention lately, but big changes are coming to the Affordable Care Act as well. Meanwhile, Americans are learning more about what’s in Trump’s big budget law, and polls suggest many don’t like what they see. Julie Appleby of KFF Health News, Jessie Hellmann of CQ Roll Call, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews historian Jonathan Oberlander to mark Medicare’s 60th anniversary.
The Senate narrowly approved the Trump administration’s request to claw back about $9 billion for foreign aid and public broadcasting but refused to cut funding for the international AIDS/HIV program PEPFAR. Meanwhile, a federal appeals court ruled that West Virginia can ban the abortion pill mifepristone, which could allow states to block other FDA-approved drugs. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more.
Children and young adults in the U.S. foster care system suffer from mental health disorders and die by suicide at far higher rates than the general population, yet the system doesn’t uniformly screen and treat children who are at risk.
Federal health officials are investigating claims that a Michigan health system fired an employee who sought a religious exemption to avoid calling transgender patients by their pronouns or referring them for gender-affirming care. Legal experts say the investigation escalates the Trump administration’s effort to curb medical care for transgender patients.
California lawmakers are poised to approve a six-month delay in implementing the state’s in vitro fertilization law, pushing its start to January 2026. The plan to postpone, which has drawn little attention, is part of the state budget package and has left patients, insurers, and employers in limbo.
While Congress fails to stave off cuts to HIV care, community leaders in Mississippi and beyond race to limit the damage.
The Supreme Court this week said Tennessee may continue to enforce its law banning most types of gender-affirming care for minors. The ruling is likely to greenlight similar laws in two dozen states. And the Senate is preparing to vote on a budget reconciliation bill that includes even deeper Medicaid cuts than the House version. Victoria Knight of Axios, Alice Miranda Ollstein of Politico, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more.
© 2026 KFF